
Tangent90 and BMJ enter a strategic partnership
Tangent90 and BMJ enter a strategic partnership. The agreement will enable BMJ to provide greater access to its scientific content and drive better engagement with healthcare professionals.
Tangent90 and BMJ enter a strategic partnership. The agreement will enable BMJ to provide greater access to its scientific content and drive better engagement with healthcare professionals.
There have been a lot of discussions online about the future of the pharma rep. The reduction in face-to-face HCP interactions during Covid may have sounded their death knell but in reality, the situation is quite different. The evolution in innovation over the last two years may have taken the limelight but the pharma rep still has an important role to play in ensuring that new technologies are used effectively to improve HCP engagement.
What does success look like? Is it simply proving return on investment – the thing all marketers talk about, and one of the hardest things to provide tangible evidence for?! Or are there other measures of success that can deliver the reassurance that the approach taken is the right one?
Tangent90 announces strategic collaboration with NEJM Group. The agreement will enable NEJM Group to provide greater access to clinical content with secure and compliant delivery to Healthcare Professionals.
Digital transformation has gathered pace in pharma and we have all been witnessing the acceleration. New technologies have been adopted to ensure HCP engagement is maintained but keeping up the understanding of innovative and emerging solutions and investing in the right technologies may prove challenging.
77% of HCPs use digital channels primarily for personal learning and development. Bitesize pieces of information are easier to digest and retain, and therefore, it makes perfect sense that often time-poor HCPs would prefer this method of content distribution.
It’s become an over-used term, hasn’t it – COVID? It seems to have been used as an excuse for everything, from airport baggage handling, to call centre queues, to the global cost of living crisis. But not every impact has been bad. Pharma, for instance, has had to expedite its digital transformation goals. The industry had to change overnight to remain in contact with its key stakeholders, healthcare professionals (HCPs).
Creating a seamless experience for HCPs across all your channels will ensure greater engagement with your brand. Enabling them to find the information they want in a format they prefer should be a key part of your omnichannel strategy. However, it’s important to remember that the HCP demographic is changing, and with that so should the method of delivering content. So how do we ensure that we serve up content that both engages the HCP and adds value for pharma?
Wednesday, July 27, 2022 | 11AM ET / 8AM PT / 4PM UK. Experts from Tangent90, Veeva Systems and Compas, Inc. will discuss why ePrints are an important part of your customer engagement strategy.
As we slowly move on from the pandemic, we are seeing a return to in-person events. Our own research shows that 100% of the 65 medical congresses we have surveyed are providing in-person events, with 40% of those providing a hybrid solution. So how does the industry manage this dual approach? And how can we ensure we keep both audiences engaged?
What have we learned from the last two years? We can share information, maintain HCP relationships, and drive acquisition, all via the click of a button. The world has well and truly embraced a digital-first approach but how do we ensure that we don’t overwhelm HCPs, simply because the method of communication is easier?
In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.